Novavax Inc (NVAX)

[Golden Cross]

INVESTORS ARE UNDERESTIMATING NOVAVAX, INC. (NVAX) AND BROOKFIELD PROPERTY PARTNERS L.P. (BPY)
By Denise Gardner - May 24, 2019


5 analysts out of 8 Wall Street brokerage firms rate Novavax, Inc. (NASDAQ:NVAX) as a Buy, while 1 see it as a Sell. The rest 2 describe it as a Hold. NVAX stock traded higher to an intra-day high of $6.17. At one point in session, its potential discontinued and the price was down to lows at $5.8982. Analysts have set NVAX’s consensus price at $25.14, effectively giving it a 310.78% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $40 (up 553.59% from current price levels). NVAX has a 136.3% ROE, higher than the 10.05% average for the industry. The average ROE for the sector is 15.24%.

It is expected that in Jun 2019 quarter NVAX will have an EPS of $-1.88, suggesting a 21.67% growth. For Sep 2019 is projected at $-1.65. It means that there could be a 31.25% growth in the quarter. Yearly earnings are expected to rise by 30.6% to about $-6.94. As for the coming year, growth will be about 21.9%, lifting earnings to $-5.42. RSI after the last trading period was 32.43. NVAX recorded a change of -4.82% over the past week and returned -84.06% over the last three months while the NVAX stock’s monthly performance revealed a shift in price of -40.16%. The year to date (YTD) performance stands at -83.37%, and the bi-yearly performance specified an activity trend of -82.21% while the shares have moved -81.89% for the past 12 months.

Novavax, Inc. (NVAX) currently trades at $6.12, which is higher by 1.16% its previous price. It has a total of 25.58 million outstanding shares, with an ATR of around 0.69. The company’s stock volume dropped to 0.7 million, worse than 1.12 million that represents its 50-day average. A 5-day decrease of about -4.82% in its price means NVAX is now -83.37% lower on year-to-date. The shares have surrendered $43591.88 since its $51.60 52-week high price recorded on 13th of December 2018. Overall, it has seen a growth rate of -81.89 over the last 12 months. The current price per share is $0.4 above the 52 week low of $5.72 set on 13th of May 2019.



Novavax, Inc. (NASDAQ:NVAX)’s EPS was $-2.2 as reported for the March quarter. In comparison, the same quarter a year ago had an EPS of $-2.8. That means that its growth in general now stands at -21%. Therefore, a prediction of $-2.21 given by the analysts brought a negative surprise of 0%. NVAX March quarter revenue was $3.98 million, compared to $9.65 million recorded in same quarter last year, giving it a -59% growth rate. The company’s $-5.67 million revenue decline that quarter surprised Wall Street and investors will need to consider this as they assess the stock.

Brookfield Property Partners L.P. (NASDAQ:BPY) shares depreciated -1.56% over the last trading period, taking overall 5-day performance up to -2.05%. BPY’s price now at $19.57 is weaker than the 50-day average of $20.48. Getting the trading period increased to 200 days, the stock price was seen at $19.25 on average. The general public currently hold control of a total of 17.06 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 429.16 million. The company’s management holds a total of 0.85%, while institutional investors hold about 67% of the remaining shares. BPY share price finished last trade -3.69% below its 20 day simple moving average and its upbeat gap from 200 day simple moving average is 1.64%, while closing the session with -4.47% distance from 50 day simple moving average.



Brookfield Property Partners L.P. (BPY) shares were last observed trading -7.78% down since April 11, 2019 when the peak of $21.22 was hit. Last month’s price growth of -5.78% puts BPY performance for the year now at 21.4%. Consequently, the shares price is trending higher by 30.82%, a 52-week worst price since Dec. 26, 2018. However, it is regaining value with 6.82% in the last 6 months.

The firm’s current profit margin over the past 12 months is 10.4%. BPY ranks lower in comparison to an average of 25.39% for industry peers; while the average for the sector is 29.43%.